Page 388 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 388
362 Sarah Conway and David S. Younger
[61] Cogan DG. Corneoscleral lesions in periarteritis nodosa and Wegener?s granulomatosis.
Trans Am. Ophthalmol. Soc., 1955; 53:321-344.
[62] Rothschild PR, Pagnoux C, Seror R, et al. Ophthalmologic Manifestations of Systemic
Necrotizing Vasculitides at Diagnosis: A Retrospective Study of 1286 Patients and
Review of the Literature. Semin. Arthritis Rheum. 2013;43:507-514.
[63] Pagnoux C, Raphael S, Henegar C, et al. Clinical features and outcomes in 348 patients
with polyarteritis nodosa. A systematic retrospective study of patients diagnosed
between 1963 and 2005 and entered into the French vasculitis study group database.
Arthritis Rheum. 2010; 62:616-626.
[64] Leung AC, McLay A, Boulton-Jones JM. Polyarteritis presenting with thrombocytosis
and central retinal vein thrombosis. Scott. Med. J., 1987; 32:24-6.
[65] Pinto Ferreira F, Faría, A, Ganhao F. Periarteritis nodosa with initial ocular
involvement. J. Fr. Ophthalmol., 1995; 18:788-793.
[66] MacClure GM. Polyarteritis nodosa with an unusual ocular presentation. Brit. J.
Ophthal., 1968; 52:141-148.
[67] Binaghi M, Kamoun MN, Coscas KG. Fluorescein angiography in the diagnosis of
periarteritis nodosa. J. Fr. Ophtalmol., 1984; 7:19-30.
[68] Akova YA, Jabbur NS, Foster CS. Ocular presentation of polyarteritis nodosa. Clinical
course and management with steroid and cytotoxic therapy. Ophthalmol.
1993;100:1775-1781.
[69] Harnden A, Mayon-White R, Perera R, et al. Kawasaki disease in England: ethnicity,
deprivation, and respiratory pathogens. Pediatr. Infect. Dis. J., 2009; 28:21-24.
[70] Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease
in Japan: results of the 2009–2010 nationwide survey. J. Epidemiol., 2012; 22: 216–
221.
[71] Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for
Kawasaki disease (the 5th revised edition). Pediatr. Int., 2005; 47:232-234.
[72] Yim D, Curtis N, Cheung M. Update on Kawasaki disease: Epidemiology, aetiology
and pathogenesis. J. Paediatr. Chil. Health, 2013; 49:704-708.
[73] Harnden A, Alves B, Sheikh A. Rising incidence of Kawasaki disease in England:
analysis of hospital admission data. BMJ, 2002; 324:1424–1425.
[74] Lin YT, Manlhiot C, Ching JC, et al. Repeated systematic surveillance of Kawasaki
disease in Ontario from 1995 to 2006. Pediatr. Int., 2010; 52: 699–706.
[75] Puglise J, Rao N, Weiss R, et al. Ocular features of Kawasaki?s disease. Arch.
Ophthalmol., 1982; 100:1101-1103.
[76] Ohno S, Miyajima T, Higuchi M, et al. Ocular manifestations of Kawasaki?s disease
(mucocutaneous lymph node syndrome). Am. J. Ophthalmol., 1982; 93:713-717.
[77] Burke MJ, Rennebohm RM. Eye involvement in KD. J. Pediatr. Ophthalmol.
Strabismus, 1981; 18:7-11.
[78] Offret H. Disciform keratitis and Kawasaki?s disease. J. Fr. Ophtalmol., 1993; 16:114-
116.
[79] Kadyan A, Choi J, Headon MP. Disciform keratitis and optic disc swelling in KD: an
unusual presentation. Eye, 2006; 20:976-977.
[80] Jacob JL, Polomeno RC, Chad Z, et al. Ocular manifestations of KD (mucocutaneous
lymph node syndrome). Can. J. Ophthalmol., 1982; 17:199-202.
Complimentary Contributor Copy
